Modeling sporadic loss of heterozygosity in mice by using mosaic analysis with double markers (MADM).
The initiation and progression of many human cancers involve either somatic activation of protooncogenes or inactivation of tumor-suppressor genes (TSGs) in sporadic cells. Although sporadic gain-of-function of protooncogenes has been successfully modeled in mice [e.g., Johnson L, Mercer K, Greenbaum D, Bronson RT, Crowley D, Tuveson DA, Jacks T (2001) Nature 410:1111-1116], generating a similar degree of sparseness of TSG loss-of-function remains a challenge. Here, we use mosaic analysis with double markers (MADM) to achieve TSG inactivation and concurrent labeling in sporadic somatic cells of mice, closely mimicking loss of heterozygosity as occurs in human cancers. As proof of principle, we studied the consequence of sporadic loss of p27kip1, a cyclin-dependent kinase inhibitor. MADM-mediated loss of p27kip1 results in mutant cell expansion markedly greater than that observed in conventional p27kip1 knockouts. Moreover, the direct comparison of WT and mutant cells at single-cell resolution afforded by MADM reveals that p27kip1 regulates organ size in vivo by cell-autonomous control of cell cycle exit timing. These studies establish MADM as a high-resolution method for modeling sporadic loss of heterozygosity in mice, providing insights into TSG function.
Muzumdar
Mandar Deepak
MD
Howard Hughes Medical Institute and Department of Biological Sciences, Stanford University, Stanford, CA 94305, USA.
Luo
Liqun
L
Zong
Hui
H
D000818:Animals; D019070:Cell Lineage; D049109:Cell Proliferation; D002531:Cerebellum / Q000378:metabolism; D050760:Cyclin-Dependent Kinase Inhibitor p27 / Q000235:genetics; D016147:Genes, Tumor Suppressor; D005821:Genetic Techniques; D006579:Heterozygote; D019656:Loss of Heterozygosity; D051379:Mice; D018345:Mice, Knockout; D008957:Models, Genetic; D009030:Mosaicism; D009154:Mutation; D019076:Transgenes
D050760:Cyclin-Dependent Kinase Inhibitor p27